Bernstein analyst Lee Hambright maintained a Buy rating on Dexcom today and set a price target of $86.00. According to TipRanks, Hambright is a 4-star analyst with an average return of 8.1% and a ...

Shares of medical device company DexCom (NASDAQ:DXCM) fell 2.6% in the morning session after analysts at Piper Sandler and ...

Supermodels, singers, and diabetics are all wearing it. Jake Leach, Dexcom CEO, says these sensors are the future.

Dexcom (NSDQ:DXCM) today announced the beginning of new CEO Jake Leach's tenure, starting with his presence at CES 2026.

Read our live updates from CES 2026 in Las Vegas to see the latest consumer gadgetry in all of its chatbot-enabled, ...

DexCom overview and recent share performance DexCom (DXCM) has drawn fresh attention as investors reassess its continuous glucose monitoring business and recent share performance, with the stock last ...

Old Republic International announced an ORI special dividend of $2.50/share. Analysts like Raymond James and Piper Sandler ...

As the United States approaches 2026, key structural shifts in retirement and healthcare financing are poised to affect how ...

In a report released on December 16, William Plovanic from Canaccord Genuity maintained a Buy rating on Dexcom, with a price target of $99.00. The company’s shares closed yesterday at $66.37. Plovanic ...

The price target increase follows updated Manufacturer and User Facility Device Experience (MAUDE) data through November 30, which showed an approximately 8% month-over-month decline in injury ...

All four Irish provinces are back in action this week across the Investec Champions and Challenge Cup pool stages. Here's everything you need to know ahead of this weekend's games.